SynthesisFrontiers in public health2025
Systematic review and meta-analysis of oral frailty prevalence among older hospitalized patients.
Synthesis in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Risk prediction models for oral frailty in older adults: a scoping review.Frontiers in medicine · 2026Pooled it
- Oral Frailty and Multidimensional Health Among Community-Dwelling Older Adults in China: A Cross-Sectional Study.Nutrients · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Oral frailty, characterized by reduced oral function, represents a significant yet understudied issue among hospitalized patients, affecting treatment outcomes. Objective: To determine the prevalence of oral frailty in hospitalized patients and identify high-risk groups through stratified analyses. Methods: Nine databases, including PubMed, Web of Science, Embase, Scopus, Cochrane Library, CNKI, SinoMed, VIP, and Wanfang, were systematically searched from their inception to July 2025. Data analysis was conducted using Stata 15.0 software, employing a random-effects model to estimate overall prevalence. Subgroup analysis and meta-regression were performed to identify sources of heterogeneity. Results: This meta-analysis included 27 studies involving 11,575 hospitalized patients. The overall prevalence of oral frailty was found to be 51% (95% CI: 47-55%). Among different disease groups, patients with cancer had the highest prevalence (62, 95% CI: 57-66%), while patients with renal disease had the lowest (39, 95% CI: 32-47%). Regional analysis indicated a prevalence of 52% (95% CI: 48-56%) among patients in mainland China, and 45% (95% CI: 37-53%) in other regions. Cross-sectional studies reported a prevalence of 52% (95% CI: 48-57%), whereas cohort studies reported 42% (95% CI: 36-48%). Disease type accounted for substantial heterogeneity (I Conclusion: The findings suggest that oral frailty is highly prevalent among hospitalized patients, with prevalence varying by disease type. Therefore, establishing specific screening programs for oral frailty and integrating professional oral care into routine medical treatment are recommended to mitigate the risk of complications. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, registration no. CRD420251107503.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.